We have completed the single ascending dose trial for namacizumab, our novel therapeutic designed to treat non-alcoholic fatty liver disease. No severe or serious adverse events were observed. Next we prepare to initiate a clinical trial in #NAFLD patients. https://bit.ly/2sB4Sze
关于我们
Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators. Backed by leading biotechnology venture investors, our strategy leverages biologic targets with substantial human proof of mechanism for the development of novel, best in class therapeutic antibodies with significant clinical and commercial differentiation.
- 网站
-
https://www.birdrockbio.com
Bird Rock Bio, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 类型
- 私人持股